Prostaglandin e2 reduces the release and infectivity of new cell-free virions and cell-to-cell HIV-1 transfer

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Clemente, María Isabel ^a,b,c   Álvarez, Susana ^a,b,c   Serramí, María Jesús ^a,b,c   Martínez Bonet, Marta ^a,b,c   Muñoz Fernández, María Ángeles ^a,b,c  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CYCLIC AMP; GAG PROTEIN; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; RAP1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; VIRUS PROTEIN; TELOMERE BINDING PROTEIN; TERF2IP PROTEIN, HUMAN; VIRUS RECEPTOR;

ACTIN POLYMERIZATION; ARTICLE; CELL PROLIFERATION; CELL TRANSFER; CONTROLLED STUDY; CYTOTOXICITY ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; PERIPHERAL LYMPHOCYTE; PROGENY; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; VIRION; VIRUS ASSEMBLY; VIRUS ENTRY; VIRUS REPLICATION; WESTERN BLOTTING; CELL LINE; HELA CELL LINE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIC AMP; DINOPROSTONE; HELA CELLS; HIV INFECTIONS; HIV-1; HUMANS; RECEPTORS, HIV; RECEPTORS, PROSTAGLANDIN E, EP2 SUBTYPE; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; SIGNAL TRANSDUCTION; TELOMERE-BINDING PROTEINS; VIRION; VIRUS REPLICATION;

EID: 84897759937     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085230     Document Type: Article

References (74)

1. Hilkens CM, Vermeulen H, van Neerven RJ, Snijdewint FG, Wierenga EA, et al. (1995) Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin-2. Eur J Immunol 25: 59-63.
2. Graziosi C, Gantt KR, Vaccarezza M, Demarest JF, Daucher M, et al. (1996) Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection. Proc Natl Acad Sci U S A 93: 4386-4391. (Pubitemid 26144297)
3. Breen EC, McDonald M, Fan J, Boscardin J, Fahey JL (2000) Cytokine gene expression occurs more rapidly in stimulated peripheral blood mononuclear cells from human immunodeficiency virus-infected persons. Clin Diagn Lab Immunol 7: 769-773.
4. Elbim C, Pillet S, Prevost MH, Preira A, Girard PM, et al. (2001) The role of phagocytes in HIV-related oxidative stress. J Clin Virol 20: 99-109. (Pubitemid 32106863)
5. Lu Y, Wahl LM (2005) Oxidative stress augments the production of matrix metalloproteinase-1, cyclooxygenase-2, and prostaglandin E2 through enhancement of NF-kappa B activity in lipopolysaccharide-activated human primary monocytes. J Immunol 175: 5423-5429. (Pubitemid 41456428)
6. Pereira CF, Boven LA, Middel J, Verhoef J, Nottet HS (2000) Induction of cyclooxygenase-2 expression during HIV-1-infected monocyte-derived macrophage and human brain microvascular endothelial cell interactions. J Leukoc Biol 68: 423-428.
7. Hayes MM, Lane BR, King SR, Markovitz DM, Coffey MJ (2002) Prostaglandin E(2) inhibits replication of HIV-1 in macrophages through activation of protein kinase A. Cell Immunol 215: 61-71.
8. Snijdewint FG, Kalinski P, Wierenga EA, Bos JD, Kapsenberg ML (1993) Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol 150: 5321-5329. (Pubitemid 23180645)
9. Betz M, Fox BS (1991) Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 146: 108-113.
10. Roper RL, Phipps RP (1994) Prostaglandin E2 regulation of the immune response. Adv Prostaglandin Thromboxane Leukot Res 22: 101-111.
11. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, et al. (1999) Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5: 698-701.
12. van der Pouw Kraan TC, van Lier RA, Aarden LA (1995) PGE2 and the immune response. A central role for prostaglandin E2 in downregulating the inflammatory immune response. Mol Med Today 1: 61.
13. Trebino CE, Stock JL, Gibbons CP, Naiman BM, Wachtmann TS, et al. (2003) Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc Natl Acad Sci U S A 100: 9044-9049. (Pubitemid 36899220)
14. Goetzl EJ, An S, Zeng L (1995) Specific suppression by prostaglandin E2 of activation-induced apoptosis of human CD4+CD8+ T lymphoblasts. J Immunol 154: 1041-1047.
15. Narumiya S, Sugimoto Y, Ushikubi F (1999) Prostanoid receptors: structures, properties, and functions. Physiol Rev 79: 1193-1226. (Pubitemid 29473315)
16. Regan JW (2003) EP2 and EP4 prostanoid receptor signaling. Life Sci 74: 143-153.
17. Aronoff DM, Oates JA, Boutaud O (2006) New insights into the mechanism of action of acetaminophen: Its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases. Clin Pharmacol Ther 79: 9-19. (Pubitemid 43069574)
18. Aronoff DM, Canetti C, Serezani CH, Luo M, Peters-Golden M (2005) Cutting edge: macrophage inhibition by cyclic AMP (cAMP): differential roles of protein kinase A and exchange protein directly activated by cAMP-1. J Immunol 174: 595-599. (Pubitemid 40094248)
19. Noda S, Yashiro M, Nshii T, Hirakawa K (2010) Hypoxia upregulates adhesion ability to peritoneum through a transforming growth factor-beta-dependent mechanism in diffuse-type gastric cancer cells. Eur J Cancer 46: 995-1005.
20. Grandoch M, Roscioni SS, Schmidt M (2010) The role of Epac proteins, novel cAMP mediators, in the regulation of immune, lung and neuronal function. Br J Pharmacol 159: 265-284.
21. Ploubidou A, Way M (2001) Viral transport and the cytoskeleton. Curr Opin Cell Biol 13: 97-105. (Pubitemid 32119299)
22. Naghavi MH, Goff SP (2007) Retroviral proteins that interact with the host cell cytoskeleton. Curr Opin Immunol 19: 402-407. (Pubitemid 47284861)
23. Jolly C, Mitar I, Sattentau QJ (2007) Adhesion molecule interactions facilitate human immunodeficiency virus type 1-induced virological synapse formation between T cells. J Virol 81: 13916-13921. (Pubitemid 350247884)
24. Sasaki H, Nakamura M, Ohno T, Matsuda Y, Yuda Y, et al. (1995) Myosinactin interaction plays an important role in human immunodeficiency virus type 1 release from host cells. Proc Natl Acad Sci U S A 92: 2026-2030.
25. Sasaki H, Ozaki H, Karaki H, Nonomura Y (2004) Actin filaments play an essential role for transport of nascent HIV-1 proteins in host cells. Biochem Biophys Res Commun 316: 588-593. (Pubitemid 38338631)
26. Mothes W, Sherer NM, Jin J, Zhong P (2010) Virus cell-to-cell transmission. J Virol 84: 8360-8368.
27. Sol-Foulon N, Sourisseau M, Porrot F, Thoulouze MI, Trouillet C, et al. (2007) ZAP-70 kinase regulates HIV cell-to-cell spread and virological synapse formation. EMBO J 26: 516-526. (Pubitemid 46160951)
28. Rudnicka D, Feldmann J, Porrot F, Wietgrefe S, Guadagnini S, et al. (2009) Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses. J Virol 83: 6234-6246.
29. Sourisseau M, Sol-Foulon N, Porrot F, Blanchet F, Schwartz O (2007) Inefficient human immunodeficiency virus replication in mobile lymphocytes. J Virol 81: 1000-1012. (Pubitemid 46067924)
30. Hubner W, McNerney GP, Chen P, Dale BM, Gordon RE, et al. (2009) Quantitative 3D video microscopy of HIV transfer across T cell virological synapses. Science 323: 1743-1747.
31. Garcia-Merino I, de Las Cuevas N, Jimenez JL, Gallego J, Gomez C, et al. (2009) The Spanish HIV BioBank: a model of cooperative HIV research. Retrovirology 6: 27.
32. Watzer B, Zehbe R, Halstenberg S, James Kirkpatrick C, Brochhausen C (2009) Stability of prostaglandin E(2) (PGE (2)) embedded in poly-D,L: -lactide-coglycolide microspheres: a pre-conditioning approach for tissue engineering applications. J Mater Sci Mater Med 20: 1357-1365.
33. Thivierge M, Le Gouill C, Tremblay MJ, Stankova J, Rola-Pleszczynski M (1998) Prostaglandin E2 induces resistance to human immunodeficiency virus-1 infection in monocyte-derived macrophages: downregulation of CCR5 expression by cyclic adenosine monophosphate. Blood 92: 40-45. (Pubitemid 28303173)
34. Greene WC, Peterlin BM (2002) Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy. Nat Med 8: 673-680. (Pubitemid 34778719)
35. Bukrinsky M (2004) A hard way to the nucleus. Mol Med 10: 1-5.
36. Dumais N, Barbeau B, Olivier M, Tremblay MJ (1998) Prostaglandin E2 Upregulates HIV-1 long terminal repeat-driven gene activity in T cells via NF-kappaB- dependent and -independent signaling pathways. J Biol Chem 273: 27306-27314. (Pubitemid 28500445)
37. Dumais N, Bounou S, Olivier M, Tremblay MJ (2002) Prostaglandin E(2)-mediated activation of HIV-1 long terminal repeat transcription in human T cells necessitates CCAAT/enhancer binding protein (C/EBP) binding sites in addition to cooperative interactions between C/EBPbeta and cyclic adenosine 5′-monophosphate response element binding protein. J Immunol 168: 274-282. (Pubitemid 34014127)
38. Gendelman HE, Theodore TS, Willey R, McCoy J, Adachi A, et al. (1987) Molecular characterization of a polymerase mutant human immunodeficiency virus. Virology 160: 323-329. (Pubitemid 17149660)
39. Laurence J, Cooke H, Sikder SK (1990) Effect of tamoxifen on regulation of viral replication and human immunodeficiency virus (HIV) long terminal repeat-directed transcription in cells chronically infected with HIV-1. Blood 75: 696-703. (Pubitemid 20069211)
40. Graziano F, Elia C, Laudanna C, Poli G, Alfano M (2011) Urokinase plasminogen activator inhibits HIV virion release from macrophage-differentiated chronically infected cells via activation of RhoA and PKCepsilon. PLoS One 6: e23674.
41. Jolly C, Mitar I, Sattentau QJ (2007) Requirement for an intact T-cell actin and tubulin cytoskeleton for efficient assembly and spread of human immunodeficiency virus type 1. J Virol 81: 5547-5560. (Pubitemid 46846995)
42. Gladnikoff M, Shimoni E, Gov NS, Rousso I (2009) Retroviral assembly and budding occur through an actin-driven mechanism. Biophys J 97: 2419-2428.
43. Cooper J, Liu L, Woodruff EA, Taylor HE, Goodwin JS, et al. (2011) Filamin A protein interacts with human immunodeficiency virus type 1 Gag protein and contributes to productive particle assembly. J Biol Chem 286: 28498-28510.
44. Lehmann M, Nikolic DS, Piguet V (2011) How HIV-1 takes advantage of the cytoskeleton during replication and cell-to-cell transmission. Viruses 3: 1757-1776.
45. Vasiliver-Shamis G, Cho MW, Hioe CE, Dustin ML (2009) Human immunodeficiency virus type 1 envelope gp120-induced partial T-cell receptor signaling creates an F-actin-depleted zone in the virological synapse. J Virol 83: 11341-11355.
46. Jolly C, Kashefi K, Hollinshead M, Sattentau QJ (2004) HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J Exp Med 199: 283-293. (Pubitemid 38129707)
47. Cui Q, So KF (2004) Involvement of cAMP in neuronal survival and axonal regeneration. Anat Sci Int 79: 209-212. (Pubitemid 40017306)
48. Nijholt IM, Dolga AM, Ostroveanu A, Luiten PG, Schmidt M, et al. (2008) Neuronal AKAP150 coordinates PKA and Epac-mediated PKB/Akt phosphorylation. Cell Signal 20: 1715-1724.
49. Davies SP, Reddy H, Caivano M, Cohen P (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95- 105.
50. Cullere X, Shaw SK, Andersson L, Hirahashi J, Luscinskas FW, et al. (2005) Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase. Blood 105: 1950-1955. (Pubitemid 40731777)
51. Hasler F, Bluestein HG, Zvaifler NJ, Epstein LB (1983) Analysis of the defects responsible for the impaired regulation of EBV-induced B cell proliferation by rheumatoid arthritis lymphocytes. II. Role of monocytes and the increased sensitivity of rheumatoid arthritis lymphocytes to prostaglandin E. J Immunol 131: 768-772. (Pubitemid 13077786)
52. Steer SA, Corbett JA (2003) The role and regulation of COX-2 during viral infection. Viral Immunol 16: 447-460. (Pubitemid 38036773)
53. Janelle ME, Gravel A, Gosselin J, Tremblay MJ, Flamand L (2002) Activation of monocyte cyclooxygenase-2 gene expression by human herpesvirus 6. Role for cyclic AMP-responsive element-binding protein and activator protein-1. J Biol Chem 277: 30665-30674. (Pubitemid 34970762)
54. Symensma TL, Martinez-Guzman D, Jia Q, Bortz E, Wu TT, et al. (2003) COX-2 induction during murine gammaherpesvirus 68 infection leads to enhancement of viral gene expression. J Virol 77: 12753-12763. (Pubitemid 37430670)
55. Pyeon D, Diaz FJ, Splitter GA (2000) Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus. J Virol 74: 5740-5745. (Pubitemid 30346612)
56. Rossen JW, Bouma J, Raatgeep RH, Buller HA, Einerhand AW (2004) Inhibition of cyclooxygenase activity reduces rotavirus infection at a postbinding step. J Virol 78: 9721-9730. (Pubitemid 39187090)
57. van Oirschot BA, Stahl M, Lens SM, Medema RH (2001) Protein kinase A regulates expression of p27(kip1) and cyclin D3 to suppress proliferation of leukemic T cell lines. J Biol Chem 276: 33854-33860.
58. Holz GG, Chepurny OG, Schwede F (2008) Epac-selective cAMP analogs: new tools with which to evaluate the signal transduction properties of cAMP-regulated guanine nucleotide exchange factors. Cell Signal 20: 10-20. (Pubitemid 350138365)
59. Roscioni SS, Elzinga CR, Schmidt M (2008) Epac: effectors and biological functions. Naunyn Schmiedebergs Arch Pharmacol 377: 345-357.
60. Gloerich M, Bos JL (2010) Epac: defining a new mechanism for cAMP action. Annu Rev Pharmacol Toxicol 50: 355-375.
61. Huang S, Wettlaufer SH, Hogaboam C, Aronoff DM, Peters-Golden M (2007) Prostaglandin E(2) inhibits collagen expression and proliferation in patientderived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling. Am J Physiol Lung Cell Mol Physiol 292: L405-413.
62. Lorenowicz MJ, van Gils J, de Boer M, Hordijk PL, Fernandez-Borja M (2006) Epac1-Rap1 signaling regulates monocyte adhesion and chemotaxis. J Leukoc Biol 80: 1542-1552. (Pubitemid 44904993)
63. Bos JL (2006) Epac proteins: multi-purpose cAMP targets. Trends Biochem Sci 31: 680-686.
64. Mei FC, Qiao J, Tsygankova OM, Meinkoth JL, Quilliam LA, et al. (2002) Differential signaling of cyclic AMP: opposing effects of exchange protein directly activated by cyclic AMP and cAMP-dependent protein kinase on protein kinase B activation. J Biol Chem 277: 11497-11504. (Pubitemid 34952919)
65. Enserink JM, Christensen AE, de Rooij J, van Triest M, Schwede F, et al. (2002) A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat Cell Biol 4: 901-906. (Pubitemid 35331366)
66. Kawasaki H, Springett GM, Toki S, Canales JJ, Harlan P, et al. (1998) A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia. Proc Natl Acad Sci U S A 95: 13278-13283. (Pubitemid 28509562)
67. Bivona TG, Wiener HH, Ahearn IM, Silletti J, Chiu VK, et al. (2004) Rap1 upregulation and activation on plasma membrane regulates T cell adhesion. J Cell Biol 164: 461-470. (Pubitemid 38174773)
68. Dustin ML, Bivona TG, Philips MR (2004) Membranes as messengers in T cell adhesion signaling. Nat Immunol 5: 363-372. (Pubitemid 38500084)
69. Nisole S, Saib A (2004) Early steps of retrovirus replicative cycle. Retrovirology 1: 9.
70. Goff SP (2007) Host factors exploited by retroviruses. Nat Rev Microbiol 5: 253-263.
71. Haraguchi H, Sudo S, Noda T, Momose F, Kawaoka Y, et al. (2010) Intracellular localization of human immunodeficiency virus type 1 Gag and GagPol products and virus particle release: relationship with the Gag-to-GagPol ratio. Microbiol Immunol 54: 734-746.
72. Blanco J, Bosch B, Fernandez-Figueras MT, Barretina J, Clotet B, et al. (2004) High level of coreceptor-independent HIV transfer induced by contacts between primary CD4 T cells. J Biol Chem 279: 51305-51314. (Pubitemid 40017876)
73. Sattentau Q (2008) Avoiding the void: cell-to-cell spread of human viruses. Nat Rev Microbiol 6: 815-826.
74. Jolly C, Sattentau QJ (2007) Human immunodeficiency virus type 1 assembly, budding, and cell-cell spread in T cells take place in tetraspanin-enriched plasma membrane domains. J Virol 81: 7873-7884. (Pubitemid 47101473)